Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Appointed director
|
|
Assure Holdings Corp. (IONM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
8-K
| Quarterly results|
Docs:
|
"Key Financial Highlights 2Q 2023 2Q 2022 YTD through Q2 2023 YTD through Q2 2022 Gross Revenue $ 4,006 $ 9,209 $ 8,796 $ 18,345 Accounts Receivable Reserve Revenue, net 1,543 1,645 5,095 6,346 Gross margin Total Operating Expenses 3,605 4,094 7,128 8,845 Net loss Adjusted EBITDA* *See Explanation of Non-GAAP Financial Measures below for an explanation of Adjusted EBITDA and a reconciliation to GAAP financial measures Management Commentary “Our second quarter results reflect the continued and constant downward pressure on reimbursement from insurance payors,” said Chief Executive Officer, John Farlinger. “We had optimistic expectations that the federal IDR process that started last year would help assist Assure and the entire healthcare industry to negotiate for equitable reimbursem..." |
|
| 05/10/2023 |
8-K
| Quarterly results|
Docs:
|
"Key Financial Highlights 1Q'23 1Q'22 Gross Revenue $ 4,790 $ 9,136 Accounts Receivable Reserve Revenue, net 3,552 4,701 Gross margin 179 824 Total Operating Expenses 3,523 4,751 Net loss Adjusted EBITDA Management Commentary “First quarter 2023 cash receipts increased from the fourth quarter of 2022 and this strength has continued into the second quarter,” said John Farlinger, Assure’s executive chairman and CEO. “We collected approximately $4.5 million of cash and reduced our average days to collect the first payment on services rendered by 16 days in the first quarter. As a reminder, we experience seasonality during the first quarter each year as more of our volume is non-commercial, resulting in reduced revenue. During 2023, we have continued to experience weakness in reimbursement r..." |
|
| 04/03/2023 |
8-K
| Quarterly results|
Docs:
|
"Key Financial Metrics FY 2022 FY 2021 Gross Revenue $ 28,854 $ 36,583 Accounts Receivable Reserve Revenue, net 10,976 29,192 Gross margin 14,874 Total Operating Expenses 23,610 17,001 Net loss Adjusted EBITDA* 1,088 *See Explanation of Non-GAAP Financial Measures below for an explanation of Adjusted EBITDA and a reconciliation to GAAP financial measures Key Operational Metrics 4Q'22 4Q'21 FY 2022 FY 2021 Remote Neurology Managed Cases 2,200 600 11,000 2,100 Total Managed Cases 5,400 5,300 21,600 17,400 Full Year 2022 Financial Summary vs. Full Year 2021 ● Total revenue was $11.0 million versus $29.2 million ● Managed cases increased 24% to a record 21,600 versus 17,400 ● Total Assure cash receipts were $21.0 million in 2022 versus $13.4 million in 2021, an increase of 5..." |
|
| 11/14/2022 |
8-K
| Quarterly results |
| 08/15/2022 |
8-K
| Quarterly results|
Docs:
|
"Key Financial Metrics 2Q'22 2Q'21 Gross Revenue $ 9,209 $ 7,320 Accounts Receivable Reserve Revenue, net 1,645 6,220 Gross Profit 3,050 Total Operating Expenses 4,094 4,516 Adjusted EBITDA *- See Explanation of Non-GAAP Financial Measures below for an explanation of Adjusted EBITDA and a reconciliation to GAAP financial measures Key Operational Metrics 2Q'22 2Q'21 Remote Neurology Managed Cases 1,900 - Total Managed Cases 5,800 4,300 * Remote neurology managed cases began in 3Q’21 7887 E. Belleview Ave Suite 500 Greenwood Village, CO 80111 287-3093 Second Quarter 2022 Financial Summary vs. Second Quarter 2021",
"Cautionary Note regarding Forward‐Looking StatementsThis presentation may contain “forward‐looking statements” within the meaning of applicable securities laws. Forward‐looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. Forward‐looking statements include, but are not limited to, statements regarding forecasts of managed cases and remote neurology managed cases, the effect of cost reductions and projected savings, financial projections, including the company being Adjusted EBITDA and cash flow positive in the second half of 2022, and other similar..." |
|
| 05/16/2022 |
8-K
| Quarterly results |
| 03/14/2022 |
8-K
| Quarterly results|
Docs:
|
"Total Managed Cases 2020 2021 1Q 2,087 2,794 2Q 1,991 4,257 3Q 2,685 4,996 4Q 3,057 5,485 Full Year 9,914 17,436",
"4Q and Full Year 2021 ResultsMarch 14, 2022 NASDAQ: IONM" |
|
| 11/15/2021 |
8-K
| Quarterly results |
| 08/16/2021 |
8-K
| Quarterly results |
| 05/26/2021 |
8-K
| Quarterly results |
| 03/26/2021 |
8-K
| Quarterly results|
Docs:
|
"ASSURE HOLDINGS CORP. CONDENSED INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION December 31, 2020 December 31, 2019 ASSETS Current assets Cash $ 4,386 $ 59 Accounts receivable, net 14,965 30,863 Income tax receivable 150 — Other assets 284 168 Due from PEs 4,856 2,489 Due from related parties 334 128 Total current assets 24,975 $ 33,707 Equity method investments 608 2,360 Property, plant and equipment, net 356 209 Operating lease right of use asset 124 196 Finance lease right of use asset 608 466 Intangibles, net 4,115 4,587 Goodwill 2,857 2,857 Total assets $ 33,643 $ 44,382 LIABILITIES AND SHAREHOLDERS' EQUITY LIABILITIES Current liabilities Accounts payable and accrued liabilities $ 2,871 $ 4,365 Current portion of debt 4,100 1,664 Current portion of lease liability 521 461 Current..." |
|
|
|